Clinical trials
Phase 3 Cognitive Dysfunction trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Recruiting | 4 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eisai Inc. | 3 |
| Eli Lilly and Company | 3 |
| Hoffmann-La Roche | 3 |
| Bristol-Myers Squibb | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| VA Office of Research and Development | 2 |
| Alzheimer's Prevention and Reversal Project, Inc. | 1 |
| Annovis Bio Inc. | 1 |
| Avid Radiopharmaceuticals | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 40 |
| Alzheimer Disease | 23 |
| Dementia | 13 |
| Memory Disorders | 4 |
| Mental Disorders | 4 |
| Nervous System Diseases | 4 |
| Brain Injuries, Traumatic | 3 |
| Psychomotor Agitation | 3 |
| Delirium | 2 |
| Down Syndrome | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.